Flag of Indiaसत्यमेव जयते
GOOD BUSINESS

Emcure subsidiary Gennova to transfer mRNA business to Immunoscript Life Science for ₹139 crore

Gennova brought out India’s first mRNA Covid vaccine

Pulse Bharat · Why it matters

The transfer of Gennova's mRNA business to Immunoscript Life Science may impact the development and availability of mRNA-based vaccines in India.

The Hindu BusinessLine Sat, 11 Jul 2026 15:51
Read the original at The Hindu BusinessLine ↗